344 / 1498
Results from the trials
Early stage disease
•
Chemotherapy improves the cure rate over radiation alone (EORTC-H7)
•
Sub-optimal chemotherapy (EBVP) needs RT for best results (EORTC-H9)
•
Reducing size of the radiation field is safe
•
Reducing the radiation dose is possible for good prognosis disease, or after
adequate chemotherapy
•
Omitting radiotherapy altogether may be possible for some patients: can we
predict who they are?